122
Participants
Start Date
June 2, 2023
Primary Completion Date
September 27, 2024
Study Completion Date
September 27, 2024
BIOTRONIK Orsiro Sirolimus-Eluting Coronary Stent System
"During the procedure, the investigator assesses the arterial diameter and lesion length either visually or using QCA to select the appropriate stent. The number of stents required for each lesion is determined by the investigator based on the specific circumstances. The length of the stent should cover from the proximal normal reference vessel to the distal normal reference vessel, ensuring complete coverage of the lesion.~The number of stents required for each lesion is determined by the investigator based on the specific circumstances. If the first stent does not fully cover the lesion, a second or even more stents may be used. In such cases, the second or additional stents are selected by the investigator based on the specific circumstances, such as using Orsiro SES stents, unless clinically contraindicated or specifically required. Please refer to the stent's Instructions for Use for the procedure.~If stent overlap occurs, the overlapping part should be at least 2mm."
The 4th Affiliated Hospital of Harbin Medical University, Harbin
Zhejiang University Mingzhou Hospital, Ningbo
Collaborators (1)
Biotronik AG
INDUSTRY
Biotronik (Beijing) Medical Device Ltd.
INDUSTRY